Published by Uma Rajagopal
Posted on January 11, 2022
The increasing demand for cell visualization and quantification using advance technique has been enabling growth in the global high content market. As per a study by Future Market Insights (FMI), driven by rising application in pharmaceutical and biotech companies, the market is poised to reach a valuation of US$ 1.5 Bn by the end of 2021. As per the study, the pharmaceutical and the healthcare sector will account for over 31% of demand registered in the market in 2021.
High content screening is adopted for drug discovery and development. Increasing research in search of the novel drug candidate and target identification & validation is expected to propel the adoption of high content screening over the forecast years. Besides this, continuous focus on manufacturing high quality and technologically advanced cell imaging system is expected to accelerate demand over the course of the forecast period.
However, due to COVID 19 outbreak, the research and development activities were hampered immensely. This is expected to have a negative impact on the market. Nonetheless, increasing investments by key manufacturers in the development of advanced cell imaging product is expected to boost the market in the coming years.
Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-426
Key Takeaways of High Content Screening Market Study
“Demand for novel technologies for cell analysis and drug discovery is expected to improve the manufacturing speed, throughput, and reliability. This is expected to create growth opportunities for market players,” Says the FMI Analyst.
Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-426
Who is Winning?
The key manufacturers in the high content screening market are involved in several partnerships and collaboration to develop new cell imaging technology. The leading manufacturers are also making their business strategies by making collaborations with international laboratories and research institutes to develop new imaging technologies.
For instance, In December 2019, Leica Microsystems make a collaboration agreement with the European Molecular Biology Laboratory (EMBL) to develop new imaging technologies applicable in life science. With this agreement EMBL and Leica promoting new imaging technologies for cell imaging.
High-Content-Screening Market by Category
Product Type
Industry
Application
Pre-Book Report@ https://www.futuremarketinsights.com/checkout/426
Valuable Insights into High Content Screening Market Study
Future Market Insights offers actionable insights and a unique perspective on the high content screening market in its latest study, presenting historical demand assessment from 2016 – 2020 and projections from 2021–2031 based on product (cell imaging & analysis, consumables, Softwares, services), industry (pharmaceutical & healthcare, biotechnology, educational institutions, independent CRO, government organizations and others), and by application (primary & secondary screening, target identification & validation, toxicity studies, compound profiling and others) in seven key regions.
Top Reports Related To Healthcare Market Insights
Enzyme Replacement Therapy Market : [305 Pages Report] The global Enzyme Replacement Therapy Market is set to be valued at US$ 9.3 Bn in 2022, and is predicted to expand at a CAGR of 6.7% to attain a net worth of US$ 13.8 Bn by the end of 2028.
Cellulite Treatment Market : [272 Pages Report] The global Cellulite Treatment Market is set to enjoy a valuation of US$ 3.3 Bn in 2022, and is predicted to expand at an impressive CAGR of 7.8% to reach a valuation of US$ 5.2 Bn by 2028.
About FMI
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
Report: https://www.futuremarketinsights.com/reports/high-content-screening-market
Press Release Source: https://www.futuremarketinsights.com/press-release/high-content-screening-market
The increasing demand for cell visualization and quantification using advance technique has been enabling growth in the global high content market. As per a study by Future Market Insights (FMI), driven by rising application in pharmaceutical and biotech companies, the market is poised to reach a valuation of US$ 1.5 Bn by the end of 2021. As per the study, the pharmaceutical and the healthcare sector will account for over 31% of demand registered in the market in 2021.
High content screening is adopted for drug discovery and development. Increasing research in search of the novel drug candidate and target identification & validation is expected to propel the adoption of high content screening over the forecast years. Besides this, continuous focus on manufacturing high quality and technologically advanced cell imaging system is expected to accelerate demand over the course of the forecast period.
However, due to COVID 19 outbreak, the research and development activities were hampered immensely. This is expected to have a negative impact on the market. Nonetheless, increasing investments by key manufacturers in the development of advanced cell imaging product is expected to boost the market in the coming years.
Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-426
Key Takeaways of High Content Screening Market Study
“Demand for novel technologies for cell analysis and drug discovery is expected to improve the manufacturing speed, throughput, and reliability. This is expected to create growth opportunities for market players,” Says the FMI Analyst.
Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-426
Who is Winning?
The key manufacturers in the high content screening market are involved in several partnerships and collaboration to develop new cell imaging technology. The leading manufacturers are also making their business strategies by making collaborations with international laboratories and research institutes to develop new imaging technologies.
For instance, In December 2019, Leica Microsystems make a collaboration agreement with the European Molecular Biology Laboratory (EMBL) to develop new imaging technologies applicable in life science. With this agreement EMBL and Leica promoting new imaging technologies for cell imaging.
High-Content-Screening Market by Category
Product Type
Industry
Application
Pre-Book Report@ https://www.futuremarketinsights.com/checkout/426
Valuable Insights into High Content Screening Market Study
Future Market Insights offers actionable insights and a unique perspective on the high content screening market in its latest study, presenting historical demand assessment from 2016 – 2020 and projections from 2021–2031 based on product (cell imaging & analysis, consumables, Softwares, services), industry (pharmaceutical & healthcare, biotechnology, educational institutions, independent CRO, government organizations and others), and by application (primary & secondary screening, target identification & validation, toxicity studies, compound profiling and others) in seven key regions.
Top Reports Related To Healthcare Market Insights
Enzyme Replacement Therapy Market : [305 Pages Report] The global Enzyme Replacement Therapy Market is set to be valued at US$ 9.3 Bn in 2022, and is predicted to expand at a CAGR of 6.7% to attain a net worth of US$ 13.8 Bn by the end of 2028.
Cellulite Treatment Market : [272 Pages Report] The global Cellulite Treatment Market is set to enjoy a valuation of US$ 3.3 Bn in 2022, and is predicted to expand at an impressive CAGR of 7.8% to reach a valuation of US$ 5.2 Bn by 2028.
About FMI
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
Report: https://www.futuremarketinsights.com/reports/high-content-screening-market
Press Release Source: https://www.futuremarketinsights.com/press-release/high-content-screening-market
Explore more articles in the Research Reports category
